Nutriband signs commercial development, clinical supply agreement with Kindeva

Nutriband has signed a commercial development and clinical supply agreement for their lead product, Aversa Fentanyl, with their partner, Kindeva Drug Delivery. Under this agreement, Kindeva will perform commercial manufacturing process development and manufacture clinical supplies for the human abuse liability clinical study required by the FDA in support of a New Drug Application. This new agreement replaces the previous feasibility agreement between the two companies which was focused on adapting Kindeva’s commercial transdermal manufacturing process to incorporate AVERSA abuse deterrent transdermal technology.